The Harvard Drug Group LLC: Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indiana
Read the official notice at FDA (drug) →
Get alerts for The Harvard Drug Group
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- The Harvard Drug Group LLC
- Product
- Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61
- Reason / hazard
- Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- US Nationwide.
- Recall initiated
- 2025-10-10
- Code info
- Lot # M04950, Exp Date: 01/2026; Lot # M04989, M04990, Exp Date: 02/2026; Lot # M05056, Exp Date: 04/2026; Lot # M05150, Exp Date: 07/2026; Lot # M05290, Exp Date: 11/2026; Lot # M05312, M05342, Exp Date: 01/2027; Lot # M05369, M05386, Exp Date: 02/2027.
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Dublin
- State
- OH
- Country
- United States
- Event id
- 97777
Free daily digest + "My products" watchlist